IntroductionMagnetic Resonance Angiography (MRA) has evolved rapidly in recent years into a widely used imaging technique of the macrovasculature. Clinical utility initially advanced considerably with the introduction of contrast-enhanced 3D MRA techniques using available standard Gd-chelate MR contrast agents. Paramagnetic contrast agents shorten the T1-relaxation time of blood; during the short intravascular phase, these agents provide signal initially in the arterial system and thereafter in the venous system, thereby enhancing the vessel to background contrast-to-noise ratio.More recently, the development of different classes of gadolinium-chelates, with preferential properties for vascular enhancement, has raised the prospect of still further advances in MRA as a routine clinical procedure. One representative of a new class of Gd-chelate is gadobenate dimeglumine Gd-BOPTA (gadobenate dimeglumine, MultiHance; Bracco Imaging, Milan, Italy). Gd-BOPTA is a gadolinium-based contrast agent, currently approved in 38 countries worldwide for MRI, whose T1 relaxivity in vivo (9.7 mmol -1 •sec -1 ) is roughly twice that of gadopentetate dimeglumine (Magnevist, Schering, Berlin, Germany) and other approved gadolinium agents, because of the capacity of the gadobenate molecule to form weak and transient interaction with serum albumin. Gd-BOPTA produced 29% higher vascular peak enhancement with a longer duration than Gd-DTPA at the same dose and flow rate [1].Several studies have shown that MultiHance-enhanced MRA in combination with 3D MR-sequences is a robust approach to non invasive imaging modality for the analysis of the entire arterial vascular tree with excellent results [2].
Supra-aortic VesselsCurrent clinical indications for MRA of the supra-aortic vessels include malformations, aneurysms, atherosclerotic disease and dissections. However, the most important indication is the detection of steno-occlusive disease of the carotid bifurcation, mainly in consideration of the fact that carotid artery disease can now be treated with minimally invasive techniques. Therapy decision are based on evaluation of the degree of stenosis and the morphology of the plaque (e.g. stability and presence of ulcerations).Several studies, including the large clinical trials NASCET [3] and ECST [4], have shown that the main indication for endoarterectomy is stenosis of >70% at the carotid bifurcation. Furthermore, endoarterectomy in patients with a symptomatic moderate carotid stenosis of 50%-69% was shown to result in a moderate reduction in the risk of stroke [5]. Other factors are also important in determining whether a carotid lesion will remain clinically silent. Plaques that are more prone to disruption, fracture or fissuring may be associated with a higher risk of embolization, occlusion and consequent ischemic neurologic events [6]. The diagnostic technique accepted as the gold standard in NASCET and ECST was digital subtraction angiography (DSA), even though DSA has several limitations, among which measurement of the exact degree...